Kilby JM - Search Results

1

Short-term safety and antiretroviral activity of T-1249, a second-generation fusion inhibitor of HIV.

Eron JJ, Gulick RM, Bartlett JA, Merigan T, Arduino R, Kilby JM, Yangco B, Diers A, Drobnes C, DeMasi R, Greenberg M, Melby T, Raskino C, Rusnak P, Zhang Y, Spence R, Miralles GD. Eron JJ, et al. Among authors: kilby jm. J Infect Dis. 2004 Mar 15;189(6):1075-83. doi: 10.1086/381707. Epub 2004 Mar 2. J Infect Dis. 2004. PMID: 14999611 Clinical Trial.

2

The safety, plasma pharmacokinetics, and antiviral activity of subcutaneous enfuvirtide (T-20), a peptide inhibitor of gp41-mediated virus fusion, in HIV-infected adults.

Kilby JM, Lalezari JP, Eron JJ, Carlson M, Cohen C, Arduino RC, Goodgame JC, Gallant JE, Volberding P, Murphy RL, Valentine F, Saag MS, Nelson EL, Sista PR, Dusek A. Kilby JM, et al. AIDS Res Hum Retroviruses. 2002 Jul 1;18(10):685-93. doi: 10.1089/088922202760072294. AIDS Res Hum Retroviruses. 2002. PMID: 12167274 Clinical Trial.

3

A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy.

Lalezari JP, Eron JJ, Carlson M, Cohen C, DeJesus E, Arduino RC, Gallant JE, Volberding P, Murphy RL, Valentine F, Nelson EL, Sista PR, Dusek A, Kilby JM. Lalezari JP, et al. Among authors: kilby jm. AIDS. 2003 Mar 28;17(5):691-8. doi: 10.1097/00002030-200303280-00007. AIDS. 2003. PMID: 12646792 Clinical Trial.

4

Safety, tolerability, and plasma pharmacokinetics of high-strength formulations of enfuvirtide (T-20) in treatment-experienced HIV-1-infected patients.

Wheeler DA, Lalezari JP, Kilby JM, Wheat J, Delehanty J, DeMasi R, Patel I, Salgo M. Wheeler DA, et al. Among authors: kilby jm. J Clin Virol. 2004 Jun;30(2):183-90. doi: 10.1016/j.jcv.2003.10.006. J Clin Virol. 2004. PMID: 15125875 Clinical Trial.

5

Evaluation of distinct blood lymphocyte populations in human immunodeficiency virus type 1-infected subjects in the absence or presence of effective therapy.

Derdeyn CA, Kilby JM, Miralles GD, Li LF, Sfakianos G, Saag MS, Hockett RD, Bucy RP. Derdeyn CA, et al. Among authors: kilby jm. J Infect Dis. 1999 Dec;180(6):1851-62. doi: 10.1086/315117. J Infect Dis. 1999. PMID: 10558941

6

Novel therapies based on mechanisms of HIV-1 cell entry.

Kilby JM, Eron JJ. Kilby JM, et al. N Engl J Med. 2003 May 29;348(22):2228-38. doi: 10.1056/NEJMra022812. N Engl J Med. 2003. PMID: 12773651 Review. No abstract available.

7

Pathological Role of Anti-CD4 Antibodies in HIV-Infected Immunologic Nonresponders Receiving Virus-Suppressive Antiretroviral Therapy.

Luo Z, Li Z, Martin L, Wan Z, Meissner EG, Espinosa E, Wu H, Yu X, Fu P, Julia Westerink MA, Kilby JM, Wu J, Huang L, Heath SL, Li Z, Jiang W. Luo Z, et al. Among authors: kilby jm. J Infect Dis. 2017 Jul 1;216(1):82-91. doi: 10.1093/infdis/jix223. J Infect Dis. 2017. PMID: 28498953 Free PMC article.

8

A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection.

Hecht FM, Wang L, Collier A, Little S, Markowitz M, Margolick J, Kilby JM, Daar E, Conway B, Holte S; AIEDRP Network. Hecht FM, et al. Among authors: kilby jm. J Infect Dis. 2006 Sep 15;194(6):725-33. doi: 10.1086/506616. Epub 2006 Aug 15. J Infect Dis. 2006. PMID: 16941337 Clinical Trial.

9

The virologic and immunologic effects of cyclosporine as an adjunct to antiretroviral therapy in patients treated during acute and early HIV-1 infection.

Markowitz M, Vaida F, Hare CB, Boden D, Mohri H, Hecht FM, Kalayjian RC, Conrad A, Mildvan D, Aberg J, Hogan C, Kilby JM, Balfour HH Jr, Schafer K, Richman D, Little S. Markowitz M, et al. Among authors: kilby jm. J Infect Dis. 2010 May 1;201(9):1298-302. doi: 10.1086/651664. J Infect Dis. 2010. PMID: 20235838 Free PMC article. Clinical Trial.

10

Prolonged suppression of human immunodeficiency virus type 1 RNA during dual nucleoside reverse-transcriptase-inhibitor therapy in clinical practice.

Hoesley CJ, Saag MS, Chatham A, Kilby JM. Hoesley CJ, et al. Among authors: kilby jm. Clin Infect Dis. 2000 Oct;31(4):1095-7. doi: 10.1086/318143. Clin Infect Dis. 2000. PMID: 11049795

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters